Cantab failure shows need for wide portfolio.
Fletcher
L
L
D001709:Biotechnology / Q000191:economics*; D003218:Condylomata Acuminata / Q000628:therapy*; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D027383:Papillomaviridae / Q000276:immunology; D030361:Papillomavirus Infections / Q000628:therapy*; D017211:Treatment Failure; D014412:Tumor Virus Infections / Q000628:therapy; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*
D014765:Viral Vaccines